Clone and Kill, Korea

News of "the 3rd International Collaborative Symposium on Stem Cell Research" — ACT’s Robert Lanza to Speak at Stem Cell Symposium in Seoul on April 29 — and that "Korea becomes the second country after the United States to start clinical tests of the controversial therapy" — Pioneering stem cell research given green light.